Arja Pasternack

2.5k total citations
73 papers, 1.6k citations indexed

About

Arja Pasternack is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arja Pasternack has authored 73 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 16 papers in Nephrology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arja Pasternack's work include Muscle Physiology and Disorders (16 papers), Renal Diseases and Glomerulopathies (12 papers) and Adipose Tissue and Metabolism (7 papers). Arja Pasternack is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Renal Diseases and Glomerulopathies (12 papers) and Adipose Tissue and Metabolism (7 papers). Arja Pasternack collaborates with scholars based in Finland, France and Germany. Arja Pasternack's co-authors include Olli Ritvos, Jukka Mustonen, Markku Korpela, Susanna Sihvonen, Juha J. Hulmi, P. Laippala, Jaakko Perheentupa, Martti Virolainen, Willem M.H. Hoogaars and David G. Mottershead and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Arja Pasternack

69 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arja Pasternack Finland 25 683 259 233 228 217 73 1.6k
Kathleen Haines United States 26 502 0.7× 170 0.7× 218 0.9× 207 0.9× 498 2.3× 44 2.0k
Alois Gessl Austria 28 527 0.8× 279 1.1× 237 1.0× 175 0.8× 146 0.7× 87 2.6k
Andrea Pasini Italy 23 378 0.6× 186 0.7× 106 0.5× 414 1.8× 101 0.5× 67 1.6k
Stefan Kröber Germany 12 570 0.8× 199 0.8× 363 1.6× 94 0.4× 204 0.9× 25 1.9k
Saverio Loddo Italy 24 400 0.6× 182 0.7× 205 0.9× 137 0.6× 85 0.4× 59 1.3k
M. I. Koolen Netherlands 14 968 1.4× 575 2.2× 126 0.5× 311 1.4× 97 0.4× 27 1.6k
Stefan Gauer Germany 22 462 0.7× 122 0.5× 125 0.5× 227 1.0× 186 0.9× 42 1.5k
Hiroo Niimi Japan 24 463 0.7× 166 0.6× 182 0.8× 187 0.8× 124 0.6× 101 1.7k
Jinyang Zeng-Brouwers Germany 18 841 1.2× 208 0.8× 119 0.5× 199 0.9× 87 0.4× 23 1.8k
Hans‐Joachim Paust Germany 29 295 0.4× 232 0.9× 126 0.5× 452 2.0× 430 2.0× 46 2.2k

Countries citing papers authored by Arja Pasternack

Since Specialization
Citations

This map shows the geographic impact of Arja Pasternack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arja Pasternack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arja Pasternack more than expected).

Fields of papers citing papers by Arja Pasternack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arja Pasternack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arja Pasternack. The network helps show where Arja Pasternack may publish in the future.

Co-authorship network of co-authors of Arja Pasternack

This figure shows the co-authorship network connecting the top 25 collaborators of Arja Pasternack. A scholar is included among the top collaborators of Arja Pasternack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arja Pasternack. Arja Pasternack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega‐Alonso, Alfredo, Harri Nurmi, Karthik Amudhala Hemanthakumar, et al.. (2025). Combined angiogenic and hypertrophic gene therapy enhances skeletal muscle growth. American Journal of Physiology-Cell Physiology. 329(2). C540–C559.
2.
Szabó, Zoltán, J. Peters, Outi Kummu, et al.. (2024). Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease. Biomedicine & Pharmacotherapy. 175. 116683–116683. 2 indexed citations
3.
Chanal, Marie, Mirela Diana Ilie, Dario De Alcubierre, et al.. (2023). Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse. Endocrine Related Cancer. 30(3). 1 indexed citations
4.
Kolehmainen, Pekka, Moona Huttunen, Sari Maljanen, et al.. (2023). Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers. Scientific Reports. 13(1). 8416–8416. 3 indexed citations
5.
Papadopoulos, Vasileios, Georgia Loli, Christina Tsigalou, et al.. (2021). The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality. The Journal of Infectious Diseases. 223(9). 1544–1554. 16 indexed citations
6.
Mitchell, Robert D., Oliver Kretz, David Chambers, et al.. (2021). A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities. Disease Models & Mechanisms. 14(2). 1 indexed citations
7.
Nissinen, Tuuli A., et al.. (2021). Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting. The FASEB Journal. 35(3). e21387–e21387. 12 indexed citations
8.
Zhao, Yajie, Zhichong Wu, Marie Chanal, et al.. (2020). Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A. Cancer Research. 80(16). 3359–3371. 28 indexed citations
9.
Nissinen, Tuuli A., Ayhan Korkmaz, Sanna Lensu, et al.. (2019). Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver. Frontiers in Physiology. 9. 1917–1917. 12 indexed citations
10.
Kainulainen, Heikki, Arja Pasternack, Timo Rantalainen, et al.. (2017). Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. BMC Musculoskeletal Disorders. 18(1). 20–20. 25 indexed citations
11.
Matsakas, Antonios, Hans Degens, Oliver Kretz, et al.. (2016). Enhanced exercise and regenerative capacity in a mouse model that violates size constraints of oxidative muscle fibres. eLife. 5. 47 indexed citations
12.
Yin, Miao, Mikko Rönty, Eva Sutinen, et al.. (2015). Overexpression of activin-A and -B in malignant mesothelioma – Attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Experimental Cell Research. 332(1). 102–115. 25 indexed citations
13.
Apostolou, Eirini, Athanasios Stavropoulos, Alexandros Sountoulidis, et al.. (2011). Activin-A Overexpression in the Murine Lung Causes Pathology That Simulates Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 185(4). 382–391. 43 indexed citations
14.
Myllymaa, Samu, Arja Pasternack, David G. Mottershead, et al.. (2009). Inhibition of oocyte growth factors in vivo modulates ovarian folliculogenesis in neonatal and immature mice. Reproduction. 139(3). 587–598. 13 indexed citations
15.
Mottershead, David G., Arja Pasternack, Samu Myllymaa, et al.. (2007). Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells. Molecular and Cellular Endocrinology. 283(1-2). 58–67. 45 indexed citations
16.
Alakuijala, Anniina, et al.. (2005). Functional characterization of rat ρ2 subunits expressed in HEK 293 cells. European Journal of Neuroscience. 21(3). 692–700. 15 indexed citations
17.
Pasternack, Arja, Sarah K. Coleman, James Féthière, et al.. (2003). Characterization of the functional role of the N‐glycans in the AMPA receptor ligand‐binding domain. Journal of Neurochemistry. 84(5). 1184–1192. 15 indexed citations
18.
Pasternack, Arja, Sarah K. Coleman, Annukka Jouppila, et al.. (2002). α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Channels Lacking the N-terminal Domain. Journal of Biological Chemistry. 277(51). 49662–49667. 67 indexed citations
19.
Pasternack, Arja. (1974). Fine-needle Aspiration Biopsy of Spleen in Diagnosis of Generalized Amyloidosis. BMJ. 2(5909). 20–22. 18 indexed citations
20.
Pasternack, Arja & Jaakko Perheentupa. (1966). HYPERTENSIVE ANGIOPATHY IN FAMILIAL CHLORIDE DIARRHŒA. The Lancet. 288(7472). 1047–1049. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026